United States securities and exchange commission logo




                                                                                
                          December 22, 2022

       Robert Weinstein
       Chief Financial Officer
       Synaptogenix, Inc.
       1185 Avenue of the Americas, 3rd Floor
       New York, New York 10036

                                                        Re: Synaptogenix, Inc.
                                                            Registration 
Statement on Form S-3
                                                            Filed December 16, 
2022
                                                            File No. 333-268831

       Dear Robert Weinstein:

              This is to advise you that we have not reviewed and will not 
review your registration
       statement.

               Please refer to Rules 460 and 461 regarding requests for 
acceleration. We remind you
       that the company and its management are responsible for the accuracy and 
adequacy of their
       disclosures, notwithstanding any review, comments, action or absence of 
action by the staff.

                                                        Please contact Daniel 
Crawford at 202-551-7767 with any questions.



                                                                                
                          Sincerely,

                                                                                
                          Division of Corporation Finance
                                                                                
                          Office of Life Sciences
       cc:                                              Daniel Bagliebter, Esq.